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RESEARCH
Cerium oxide nanoparticles attenuate 
acute kidney injury induced by intra-abdominal 
infection in Sprague–Dawley rats
Nandini D. P. K. Manne1,2,3, Ravikumar Arvapalli1, Niraj Nepal1,4, Tolou Shokuhfar5, Kevin M. Rice1, 
Shinichi Asano1 and Eric R. Blough1,3,4*
Abstract 
Background: Intra-abdominal infection or peritonitis is a cause for great concern due to high mortality rates. The 
prognosis of severe intra-abdominal infection is significantly diminished in the presence of acute kidney injury (AKI) 
which is often characterized by renal tubular cell death that can lead to renal failure. The purpose of the current study 
is to examine the therapeutic efficacy of cerium oxide (CeO2) nanoparticles for the treatment of peritonitis-induced 
AKI by polymicrobial insult.
Results: A one-time administration of CeO2 nanoparticles (0.5 mg/kg) in the absence of antibiotics or other sup-
portive care, attenuated peritonitis-induced tubular dilatation and the loss of brush border in male Sprague–Dawley 
rats. These improvements in renal structure were accompanied by decreases in serum cystatin-C levels, reduced renal 
oxidative stress, diminished Stat-3 phosphorylation and an attenuation of caspase-3 cleavage suggesting that the 
nanoparticle treatment improved renal glomerular filtration rate, diminished renal inflammation and reduced renal 
apoptosis. Consistent with these data, further analysis demonstrated that the CeO2 nanoparticle treatment dimin-
ished peritonitis-induced increases in serum kidney injury molecule-1 (KIM-1), osteopontin, β-2 microglobulin and 
vascular endothelial growth factor-A (VEGF-A) levels. In addition, the nanoparticle attenuated peritonitis-induced 
hyperglycemia along with increases in blood urea nitrogen (BUN), serum potassium and sodium.
Conclusion: CeO2 nanoparticles scavenge reactive oxygen species and attenuate polymicrobial insult induced 
increase in inflammatory mediators and subsequent AKI. Taken together, the data indicate that CeO2 nanoparticles 
may be useful as an alternative therapeutic agent or in conjunction with standard medical care for the treatment of 
peritonitis induced acute kidney injury.
Keywords: Cerium oxide nanoparticles, Polymicrobial insult, Acute kidney injury, Reactive oxygen species, Peritonitis
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Background
Intra-abdominal infection-induced peritonitis is charac-
terized by an overwhelming immune response in reac-
tion to the presence of infectious agents that can lead to 
multi-organ failure and death if not properly managed. 
Acute kidney injury (AKI) induced by polymicrobial 
insult is a cause of great concern as it increases mortal-
ity rates and is also associated with increased financial 
burden and length of hospital stay [1]. Despite advances 
in medical science and care, sepsis still baffles the 
research community due to its complex pathophysiology 
and rapid progression making current therapeutic inter-
ventions ineffective.
Intra-abdominal infection-induced acute renal failure 
is caused by a multitude of factors that includes com-
ponents of ischemia–reperfusion injury, hypoperfusion, 
endothelial dysfunction, coagulation defects, cytokine 
storm and apoptosis [2–4]. Most studies to-date point 
that the single most cause for intra-abdominal infec-
tion induced AKI is the development of the systemic 
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inflammatory response syndrome (SIRS) which is medi-
ated by increased oxidative stress [5, 6]. Other stud-
ies have shown that intra-abdominal infection causes 
injury to renal tubular cells by damaging the endothelium 
that leads to increased permeability [7]. These changes 
are histologically evident by loss of brush border and 
increased tubular dilatation [8]. At the cellular level, it 
is presumed that polymicrobial insult causes tubular cell 
death by caspase mediated apoptosis [2]. As such thera-
peutic interventions directed towards elimination of 
reactive oxygen species (ROS) may be warranted for the 
treatment of AKI.
Recent developments in nanotechnology have given 
rise to several promising compounds that can effectively 
scavenge ROS [9–11]. Among those, CeO2 nanoparti-
cles have been increasingly used in biomedical field for 
the treatment of various pathologies involving oxidative 
stress [12, 13] and inflammation [14, 15]. A property that 
is unique to CeO2 nanoparticles is the ability to cycle 
between Ce+3 (reduced) and Ce+4 (oxidized) states which 
allows them to effectively scavenge ROS [16]. Other 
studies have shown that CeO2 nanoparticles behave as 
a superoxide dismutase [17] and catalase [18] mimetic 
depending on the redox state of the particles. Researches 
have exploited this property of CeO2 nanoparticles for 
the treatment of diabetes [19, 20], cancer [21, 22] and 
ischemic stroke [23].
Previously we have shown that CeO2 nanoparticles 
inhibit intra-abdominal infection induced liver and heart 
dysfunction [24]. Whether CeO2 nanoparticles can be 
used to attenuate polymicrobial insult-induced AKI is 
not known. In continuation with our previous study, we 
evaluated the therapeutic efficacy of CeO2 nanoparticles 
for the treatment of polymicrobial insult-induced AKI 
by examining the effect of nanoparticle intervention on 
renal histological damage, oxidative stress, inflammation, 
apoptosis and changes in circulating AKI biomarkers.
Results
Characterization of nanoceria
Scanning transmission electron microscopy (STEM) was 
used to demonstrate the ordered structure of nanoparti-
cles while transmission electron microscopy (TEM) dem-
onstrated the size of CeO2 nanoparticles to be in between 
10-40 nm (Fig. 1a, b). Energy dispersive X-ray spectros-
copy (EDS) indicated that the content of cerium and oxy-
gen in the sample to be 80.38 and 16.26  %, respectively 
(Fig. 1c).
Cerium oxide nanoparticles attenuate peritonitis induced 
renal damage and breakdown of tubular F‑actin
Polymicrobial insult-induced AKI was characterized by 
renal tubular dilatation, loss of brush border and damage 
to the glomerular capillary network (Fig.  2c, g) which 
appeared to be attenuated with nanoparticle treatment 
(Fig.  2d, h). Renal sections of peritonitis induced ani-
mals showed marked loss of F-actin in proximal tubular 
cells (Fig.  3c) which was attenuated with nanoparticle 
treatment (Fig. 3d). The mean fluorescence intensity for 
F-actin was higher in peritonitis +CeO2 group by 61  % 
when compared to peritonitis group alone (Fig.  3e) 
(P < 0.05). 
Cerium oxide nanoparticles attenuate peritonitis induced 
oxidative stress, stat‑3 activation, cleavage of caspase 3 
and serum biomarkers of renal failure
Compared to control and treated animals, the renal sec-
tions obtained from animals suffering from peritonitis 
exhibited increased superoxide levels (Fig. 4c, e; P < 0.05). 
Similarly, nanoparticle treatment decreased peritonitis 
induced increases in the ratio of phosphorylated to total 
levels of Stat-3 (Fig. 5a; P < 0.05) and caspase-3 cleavage 
(Fig. 5b; P < 0.05) at 18 h. Compared to the control group 
and treated animals, peritonitis increased the levels of 
β-2 microglobulin at 3 h and 18 h and the levels of KIM-
1, cystatin-C, osteopontin and VEGF-A at 18 h (Table 1; 
P < 0.05).
Cerium oxide nanoparticles attenuate peritonitis induced 
changes in serum biochemical parameters
Peritonitis caused a decrease in serum levels of sodium 
at 3  h and an increase in levels of potassium at 18  h 
(Table  2; P  <  0.05). Nanoparticle treatment attenuated 
peritonitis-induced changes in serum sodium and potas-
sium (Table  2; P  <  0.05). Similarly, peritonitis induced 
early hyperglycemia and increases in levels of BUN at 3 h 
time point were attenuated with nanoparticles treatment 
(Table 2; P < 0.05).
Discussion
Intra-abdominal infection or peritonitis-induced AKI 
has a poor prognosis despite recent advances in medi-
cal care. Studies have shown that peritonitis-induced 
AKI is associated with increases in oxidative and nitro-
sative stress which promote renal inflammation, tubu-
lar dilatation, vacuolization, sloughing of epithelial cells 
and loss of brush border which if severe can cause renal 
failure [25, 26]. CeO2 nanoparticles have been shown to 
act as an anti-oxidant and anti-inflammatory agent in 
the treatment of several diseases including cancer and 
diabetes [27, 28]. Similarly, previous work by our labora-
tory has showed that CeO2 nanoparticles can attenuate 
intra-abdominal infection-induced animal death along 
with liver and heart damage [24]. With this in mind, we 
hypothesized that CeO2 nanoparticles could be used to 
prevent peritonitis induced AKI.
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Fig. 1 Characterization of CeO2 nanoparticles. a Scanning transmission electron microscopy (STEM), b Transmission electron microscopy (TEM),  
c Energy-Dispersive X-Ray Spectroscopy (EDS)
Fig. 2 CeO2 nanoparticles attenuate peritonitis induced renal damage. Hematoxylin and eosin staining of kidney sections 18 h after polymicrobial 
insult. a Control, b CeO2, c Peritonitis, d Peritonitis + CeO2 (200× magnification), e Control, f CeO2, g Peritonitis, h Peritonitis + CeO2 (400× magni-
fication) (n = 4/group)
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Previous studies have shown that peritonitis induced 
by polymicrobial insult leads to marked tubular damage 
along with loss of brush border and derangement in glo-
merular capillary network [29]. We found that the CeO2 
nanoparticle treatment attenuated peritonitis-induced 
damage to the renal glomeruli and tubules (Fig. 1). AKI is 
characterized by the loss of F-actin that leads to disrup-
tion in cytoskeleton network and impairs renal structural 
and functional integrity [30]. To address this possibility, 
we next sought to determine whether the nanoparticles 
can prevent peritonitis-induced changes in renal struc-
tural integrity. As expected we found that peritonitis 
caused a significant decrease F-actin associated fluores-
cence which appeared to be attenuated with CeO2 nan-
oparticle treatment (Fig.  3). Taken together, these data 
suggest that the nanoparticle treatment was associated 
with diminished AKI.
It is thought that peritonitis is characterized by 
increases in oxidative stress which can result in an uncon-
trolled systemic inflammatory response and multi-organ 
failure [31]. Studies have shown that CeO2 nanoparti-
cles are potent ROS scavengers and that they can act as 
catalase and SOD mimetics [32]. Supporting these data, 
we found that CeO2 nanoparticle treatment significantly 
attenuated peritonitis induced-increases in renal superox-
ide oxide levels (Fig. 4). To extend these findings, we next 
examined the phosphorylation (activation) of the inflam-
matory mediated Jak-Stat proteins [33]. The Jak-Stat 
pathway has been shown to participate in the develop-
ment of diabetic nephropathy, renal fibrosis and ischemia 
reperfusion injury where it functions as a key regulator 
of cytokine and growth factor signaling [34]. Additional 
data has also demonstrated that Stat-3 signaling is neces-
sary for the hypoxia-induced transcription of VEGF [35]. 
Here we found that peritonitis-induced the activation of 
Stat-3 and increased serum VEGF levels. (Fig. 5a; Table 1). 
Fig. 3 CeO2 nanoparticles attenuate peritonitis induced loss of 
F-actin. Rhodamine phalloidin staining of F-actin of kidney sec-
tions 18 h after polymicrobial insult. a Control, b CeO2, c Peritonitis, d 
Peritonitis + CeO2 and e Relative fluorescence intensity as a measure 
of F-actin levels. 200× magnification. *P < 0.05 compared to control 
group, $P < 0.05 compared to CeO2 group and 
#P < 0.05 compared to 
peritonitis group (n = 3/group)
Fig. 4 CeO2 nanoparticles attenuate peritonitis induced increase in 
renal superoxide levels. Dihydroethidium staining of kidney sections 
at 18 h after polymicrobial insult. a Control, b CeO2, c Peritonitis, d 
Peritonitis + CeO2 and e Quantification of superoxide levels in dif-
ferent groups. 200× magnification. *P < 0.05 compared to control 
group, $P < 0.05 compared to CeO2 group and 
#P < 0.05 compared to 
peritonitis group (n = 4/group)
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Similarly, a growing body of evidence suggests that the 
apoptosis of renal tubular cells is one of the major causes 
for AKI in peritonitis induced by polymicrobial insult [36]. 
Other work has demonstrated that the cleavage of cas-
pase-3 activates gelsolin which has F-actin severing prop-
erties [37]. The loss of F-actin in turn, causes cytoskeletal 
derangement that can result in apoptotic cell death [30]. 
In agreement with our fluorescent measurement of actin 
levels, we found that peritonitis induced-cleavage of cas-
pase-3 was significantly attenuated by CeO2 nanoparti-
cle treatment (Figs. 3, 5a). Taken together and consistent 
with our histological findings of diminished renal damage, 
these data suggest that nanoparticle treatment is associ-
ated with decreased renal superoxide levels, reduced renal 
inflammation, and diminished renal apoptosis.
In addition to changes in cellular structure, AKI has 
also been shown to be associated with decreases in glo-
merular filtration rate and alterations in serum KIM-1, 
β-2 microglobulin, and osteopontin levels [38–40]. As 
expected, peritonitis was associated with alterations in 
the serum level of all of these variables which appeared 
to be significantly diminished with nanoparticle treat-
ment (Table  1). In a similar fashion, hyponatremia, 
hyperkalemia, hyperglycemia, and increased blood urea 
nitrogen levels are generally found in acute renal failure 
with decreased renal tubular flow rate [8, 41]. Consist-
ent with these findings, we found similar changes in the 
present study, and importantly, demonstrated a reduc-
tion in these variables with nanoparticle treatment 
(Table 2).
Fig. 5 CeO2 nanoparticles attenuate peritonitis induced renal inflammation and apoptosis. a Levels of phosphorylated to total Stat-3. b Relative 
levels of cleaved caspase-3 and c Relative levels of caspase-3 as determined by immunoblotting. *P < 0.05 compared to control group, $P < 0.05 
compared to CeO2 group and 
#P < 0.05 compared to peritonitis group (n = 5–6/group)
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Conclusion
The results of the current study suggest that a single, 
“stand-alone” dose of CeO2 nanoparticles confers protec-
tion against severe polymicrobial insult-induced acute 
kidney injury. Our data suggest that the CeO2 nanopar-
ticles act by scavenging reactive oxygen species which is 
associated with diminished caspase-3 activation, reduced 
loss of F-actin and less damage to the tubules. Improve-
ments in kidney structure were accompanied by evi-
dence of increased renal function and decreased serum 
biomarker levels of renal injury (Fig. 6). Taken together, 
these data suggest that further investigation into the 
potential utility of using CeO2 nanoparticles for the treat-
ment of polymicrobial-induced AKI may be warranted.
Methods
Characterization of CeO2 nanoparticles
CeO2 nanoparticles were commercially purchased from 
US Research Nanomaterials Inc. (Houston, TX, USA). 
Scanning transmission electron microscopy (STEM) 
images were obtained by using Aberration Corrected 
Analytical Electron Microscope (TEM/STEM JEOL 
JEM-ARM200CF, Japan) operated at 200  keV. Particle 
size was obtained using JEOL JEM-2010 transmission 
electron microscope (TEM). Sample purity was esti-
mated by energy dispersive X-ray spectroscopy using 
Noran Voyager EDX software.
Polymicrobial insult and CeO2 nanoparticle treatment
Male Sprague–Dawley rats aged 10  weeks were pur-
chased from Hill-Top laboratories and allowed to 
acclimatize for 2 weeks prior to experimentation. All sur-
gical procedures were performed in accordance with the 
guidelines provided by Marshall University Institutional 
Animal Care and Use Committee (IACUC), and Asso-
ciation for Assessment and Accreditation of Laboratory 
Animal Care (AAALAC). Briefly, animals were anesthe-
tized under isoflurane and a small mid ventral incision of 
0.5 cm was made. Sham controls and CeO2 only groups 
were injected with 5 ml/kg of 5 % sterile dextrose solu-
tion intra-peritoneally (i.p) while peritonitis and perito-
nitis +CeO2 groups received cecal inoculum of 600 mg/
kg BW in 5 ml/kg BW of 5 % sterile dextrose solution i.p 
as described previously [42]. Cecal material was obtained 
Fig. 6 Schematic representation of mechanism of action of CeO2 nanoparticles on polymicrobial insult induced AKI
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from healthy donor rats. The sham control and perito-
nitis groups were injected with 200 µl of sterile distilled 
water intravenously while the CeO2 and peritonitis 
+CeO2 groups received CeO2 nanoparticles (0.5 mg/kg) 
in 200 µl of sterile distilled water via tail vein injection.
Tissue collection
Animals were humanely sacrificed under anesthesia and 
the kidneys were excised, capsule removed and washed 
in Krebs–Ringer bicarbonate buffer (KRB) to remove any 
blood. Kidneys were frozen in liquid nitrogen and stored 
at −80  °C until further analysis. Serum was obtained 
from whole blood by centrifugation at 5000×g for 10 min 
at room temperature and stored at −80 °C.
Renal histology and staining for F‑actin
Frozen kidneys were sectioned (4 µm) with a Leica CM1950 
cryostat and transferred to poly-l-lysine coated slides. 
Hematoxylin and eosin staining was performed using His-
toperfect kit (BBC Biochemical, Seattle WA, USA) to assess 
kidney morphology and imaged using Evos XL microscope 
(Life Technologies, Grand Island, NY, USA).
Renal sections were stained for F-actin using rhoda-
mine phalloidin (Life technologies, Grand Island, NY, 
USA). Briefly, frozen sections were washed with PBS and 
fixed in 4 % methanol free formaldehyde for 10 min and 
washed with PBS (3 × 5 min). Sections were then perme-
abilized with 0.3 % Triton X-100 in PBS for 20 min and 
washed with PBS (3 ×  5  min). After blocking with 1  % 
BSA for 30 min, the tissue sections were incubated with 
0.165  µM rhodamine phalloidin for 20  min in the dark, 
washed with PBS (3  ×  5  min), cover slipped and then 
imaged with a Evos FL microscope (Life Technologies, 
Grand Island, NY, USA). Four images per section from at 
least three different animals from each group were evalu-
ated for fluorescence intensity using Image J analysis 
software.
Estimation of renal superoxide levels
Superoxide levels in renal sections were estimated using 
dihydroethidium staining as described previously [43]. 
Briefly, sections were washed with PBS and incubated 
with 5 mM dihydroethidium for 1 h at room temperature 
in the dark. After washing with PBS (3 × 5 min), sections 
were imaged with an Evos FL microscope (Life Technolo-
gies, Grand Island, NY, USA). Four images per section 
from at least four different animals from each group were 
evaluated for fluorescence intensity using Image J analy-
sis software.
SDS‑PAGE and immunoblotting
Approximately 100  mg of frozen kidney was taken and 
pulverized to a fine powder, suspended in 900 µl of T-PER 
(Pierce, Rockford, IL, USA) containing 1 % protease and 
phosphatase inhibitors and homogenized. Supernants 
were collected by centrifugation (10,000×g for 10  min 
at 4  °C and the protein concentration determined using 
the 660  nm assay (Pierce, Rockford, IL, USA). Samples 
were equally diluted with 4× Laemilli buffer and then 
subjected to electrophoresis on 10 % PAGEr Gold Precast 
gel (Lonza, Rockland, ME, USA) before transfer to nitro-
cellulose membranes as detailed elsewhere [44]. Equal 
loading of protein was verified by Ponceau S staining of 
nitrocellulose membranes. Membranes were blocked 
with 5 % milk in TBST for 1 h and later probed with pri-
mary antibodies against p-stat-3 (Tyr 705), stat-3, cleaved 
caspase-3 and caspase-3 (Cell Signaling Technology, 
Danvers, MA, USA). After exposure to the primary anti-
bodies, membranes were washed with TBST (3 × 5 min) 
and incubated with secondary anti-rabbit (Cell Signaling 
Technology, Danvers, MA, USA) for 1 h at room temper-
ature. Immunoreactivity was visualized using Supersignal 
West Pico Chemiluminiscent substrate (Pierce, Rockford, 
IL, USA) and quantified by Fluorchem 9900 software 
(Protein Simple, Santa Clara, CA, USA).
Multiplex immunoassay and serum biochemical analysis
Serum samples from different animals in each group 
were pooled and sent to Myriad RBM (Austin, TX, USA) 
for the analysis of KIM-1, cystatin-C, osteopontin, β-2 
microglobulin and VEGF-A using the rodent kidney 
MAP. Samples were run in triplicate for statistical analy-
sis. The amount of glucose, BUN, sodium and potassium 
were determined in serum using an Abaxis VetScan® 
analyzer (Abaxis, Union City, CA, USA).
Statistical analysis
Results are presented in the form of mean  ±  stand-
ard error of mean. Differences in dependent variables 
across groups were determined by one way analysis of 
variance (ANOVA) with Student Newman Keul’s post 
hoc analysis or ANOVA on ranks with Student New-
man Keul’s post hoc analysis for non-normally distrib-
uted samples. Where appropriate a t test was used. A 
probability value of P < 0.05 was accepted to be statisti-
cally significant.
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